Application Sponsors
ANDA 205646 | HETERO LABS LTD V | |
Marketing Status
Prescription | 001 |
None (Tentative Approval) | 002 |
Application Products
001 | TABLET;ORAL | 30MG | 0 | TOLVAPTAN | TOLVAPTAN |
002 | TABLET;ORAL | 15MG | 0 | TOLVAPTAN | TOLVAPTAN |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2021-07-16 | STANDARD |
UNKNOWN; | ORIG | 2 | TA | 2021-07-16 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
CDER Filings
HETERO LABS LTD V
cder:Array
(
[0] => Array
(
[ApplNo] => 205646
[companyName] => HETERO LABS LTD V
[docInserts] => ["",""]
[products] => [{"drugName":"TOLVAPTAN","activeIngredients":"TOLVAPTAN","strength":"30MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"TOLVAPTAN","submission":"TOLVAPTAN","actionType":"30MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)